Richmond Healthcare Limited 12431664 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is wholesale of pharmaceutical goods. Digita Accounts Production Advanced 6.30.9574.0 true 12431664 2023-02-01 2024-01-31 12431664 2024-01-31 12431664 core:CurrentFinancialInstruments 2024-01-31 12431664 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 12431664 bus:SmallEntities 2023-02-01 2024-01-31 12431664 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 12431664 bus:FullAccounts 2023-02-01 2024-01-31 12431664 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 12431664 bus:RegisteredOffice 2023-02-01 2024-01-31 12431664 bus:Director1 2023-02-01 2024-01-31 12431664 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 12431664 countries:AllCountries 2023-02-01 2024-01-31 12431664 2022-02-01 2023-01-31 12431664 core:CurrentFinancialInstruments 2023-01-31 12431664 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 iso4217:GBP xbrli:pure

Registration number: 12431664

Richmond Healthcare Limited

Unaudited Financial Statements

for the Year Ended 31 January 2024

 

Richmond Healthcare Limited

Contents

Statement of Financial Position

1

Notes to the Unaudited Financial Statements

2 to 4

 

Richmond Healthcare Limited

(Registration number: 12431664)
Statement of Financial Position as at 31 January 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

1

1

Capital and reserves

 

Called up share capital

1

1

Shareholders' funds

 

1

1

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Income Statement .

Approved and authorised by the director on 30 July 2024
 

.........................................
Mr Iqbal Moosa
Director

   
     
 

Richmond Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales .

The address of its registered office is:
Newlands House
60 Chain House Lane
Whitestake
Preston
PR4 4LG

These financial statements were authorised for issue by the director on 30 July 2024.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

 

Richmond Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.

Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised


 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Debtors

 

Richmond Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024

Current

2024
£

2023
£

Other debtors

1

1

 

1

1